Advertisement
Canada markets open in 4 hours 33 minutes

  • S&P/TSX

    21,656.05
    +13.18 (+0.06%)
     

  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • CAD/USD

    0.7271
    +0.0007 (+0.10%)
     

  • CRUDE OIL

    82.36
    -0.33 (-0.40%)
     

  • Bitcoin CAD

    84,397.68
    -2,744.67 (-3.15%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,394.10
    +5.70 (+0.24%)
     

  • RUSSELL 2000

    1,947.95
    -19.53 (-0.99%)
     

  • 10-Yr Bond

    4.5850
    0.0000 (0.00%)
     

  • NASDAQ futures

    17,726.50
    +68.00 (+0.39%)
     

  • VOLATILITY

    18.03
    -0.18 (-0.99%)
     

  • FTSE

    7,883.93
    +35.94 (+0.46%)
     

  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     

  • CAD/EUR

    0.6807
    +0.0005 (+0.07%)
     

Anacor Pharmaceuticals (ANAC) Shares March Higher, Can It Continue? - Tale of the Tape

Zacks Equity Research
Updated

As of late, it has definitely been a great time to be an investor in Anacor Pharmaceuticals Inc (ANAC). The stock has moved higher by 21.8% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider ANAC’s recent earnings estimate revision activity. From this look, the company’s future is quite favorable; as ANAC has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn’t the top for the in-focus company.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
ANACOR PHARMACT (ANAC): Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research